Table 2: Relationship between Fas mRNA expression
levels and EGF doses in the groups.
|
EGF |
Expression Value (2-∆∆CT) |
25% |
75% |
Pa |
|
|
C |
0 |
0.75 |
0.10 |
1.00 |
0.839 |
|
1 |
0.49 |
0.09 |
1.00 |
||
|
2 |
0.82 |
0.24 |
1.00 |
||
|
3 |
0.22 |
0.12 |
1.00 |
||
|
GU |
0 |
0.39 |
0.11 |
1.00 |
0.291 |
|
1 |
1.00 |
0.61 |
1.00 |
||
|
2 |
0.62 |
0.03 |
1.00 |
||
|
3 |
0.51 |
0.38 |
1.00 |
||
|
DU |
0 |
1.00 |
0.07 |
1.00 |
0.918 |
|
1 |
1.00 |
0.12 |
1.00 |
||
|
2 |
1.00 |
0.07 |
1.00 |
||
|
3 |
1.00 |
0.10 |
1.00 |
||
|
N87 |
0 |
0.04 |
0.02 |
1.00 |
0.244 |
|
1 |
1.00 |
0.02 |
1.14 |
||
|
2 |
0.01*# |
0.01 |
0.05 |
||
|
3 |
1.00 |
0.40 |
1.05 |
||
|
Pb |
0 |
0.671 |
|
||
|
1 |
0.557 |
||||
|
2 |
0.006 |
||||
|
3 |
0.622 |
||||
C: Control, GU: Gastric Ulcer, DU: Duodenal Ulcer,
N87: Gastric cancer cell line, Pa: The comparison between EGF doses
of expression values for each group, Pb: The
comparison between the groups of expression values for each EGF dose (0: Kontrol; 1: 20 ng/µl EGF; 2: 50 ng/µl EGF; 3: 100 ng/µl
EGF).
*p ≤ 0.05 when compared to control #p
≤ 0.05 when compared to DU.